Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,601 to 1,620 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Contact System Activation in Plasma from Dengue Patients Might Harness Endothelial Virus Replication through the Signaling of Bradykinin Receptors. | Pharmaceuticals (Basel) | 2021 | 33445640 | PubTator, text mining | PubMed |
| Pathophysiology of Hereditary Angioedema (HAE) Beyond the SERPING1 Gene. | Clin Rev Allergy Immunol | 2021 | 33442779 | PubTator, text mining | PubMed |
| Sugar Matters: Improving In Vivo Clearance Rate of Highly Glycosylated Recombinant Plasma Proteins for Therapeutic Use. | Pharmaceuticals (Basel) | 2021 | 33440845 | PubTator, text mining | PubMed |
| Clinically distinct COVID-19 cases share notably similar immune response progression: A follow-up analysis. | Heliyon | 2021 | 33437888 | PubTator, text mining | PubMed |
| Transcriptomic Profiling of Equine and Viral Genes in Peripheral Blood Mononuclear Cells in Horses during Equine Herpesvirus 1 Infection. | Pathogens | 2021 | 33430330 | PubTator, text mining | PubMed |
| Biologics for atopic diseases: Indication, side effect management, and new developments. | Allergol Select | 2021 | 33426426 | PubTator, text mining | PubMed |
| Current and Prospective Targets of Pharmacologic Treatment of Hereditary Angioedema Types 1 and 2. | Clin Rev Allergy Immunol | 2021 | 33423210 | PubTator, text mining | PubMed |
| Psychological processes in the experience of hereditary angioedema in adult patients: an observational study. | Orphanet J Rare Dis | 2021 | 33422102 | PubTator, text mining | PubMed |
| Partial inhibition of mitochondrial complex I ameliorates Alzheimer's disease pathology and cognition in APP/PS1 female mice. | Commun Biol | 2021 | 33420340 | PubTator, text mining | PubMed |
| B Cells and Antibodies as Targets of Therapeutic Intervention in Neuromyelitis Optica Spectrum Disorders. | Pharmaceuticals (Basel) | 2021 | 33419217 | PubTator, text mining | PubMed |
| Regulation of Complement Activation by Heme Oxygenase-1 (HO-1) in Kidney Injury. | Antioxidants (Basel) | 2021 | 33418934 | PubTator, text mining | PubMed |
| Identification of dysregulated pathways underlying HTLV-1-associated myelopathy/tropical spastic paraparesis through co-expression network analysis. | J Neurovirol | 2021 | 33405203 | PubTator, text mining | PubMed |
| Psychology and hereditary angioedema: A systematic review. | Allergy Asthma Proc | 2021 | 33404395 | PubTator, text mining | PubMed |
| Effect of Anabolic-Androgenic Steroid Abuse on the Contact Activation System. | Thromb Haemost | 2021 | 33401331 | PubTator, text mining | PubMed |
| Complement inhibitor for therapy of CHAPLE. | Nat Immunol | 2021 | 33398184 | PubTator, text mining | PubMed |
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19). | Trials | 2021 | 33397449 | PubTator, text mining | PubMed |
| Predicting changes in renal metabolism after compound exposure with a genome-scale metabolic model. | Toxicol Appl Pharmacol | 2021 | 33387578 | PubTator, text mining | PubMed |
| Is the Angioedema Associated with COVID-19 a Real Entity, a Mimic, or Both? | Am J Respir Crit Care Med | 2021 | 33357169 | PubTator, text mining | PubMed |
| Reply to Chan and Majluf-Cruz: Is the Angioedema Associated with COVID-19 a Real Entity, a Mimic, or Both? | Am J Respir Crit Care Med | 2021 | 33357023 | PubTator, text mining | PubMed |
| The Panorama of Primary Angioedema in the Brazilian Population. | J Allergy Clin Immunol Pract | 2021 | 33276216 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=81